820826215	820826215	CD	B-NP	O
|	|	NN	I-NP	O
CCH	CCH	NN	I-NP	O
|	|	NN	I-NP	O
98532506	98532506	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8876870	8876870	CD	B-NP	O
|	|	CC	I-NP	O
9/18/2003	9/18/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ISCHEMIC	ISCHEMIC	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/2/2003	5/2/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2003	7/15/2003	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
said	say	VBD	B-VP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
developed	develop	VBD	B-VP	O
about	about	IN	B-PP	O
a	a	DT	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
stress	stress	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
died	die	VBD	B-VP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
from	from	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
palpitations	palpitation	NNS	I-NP	O
developed	develop	VBD	B-VP	O
she	she	PRP	B-NP	O
assumed	assume	VBD	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
feel	feel	VB	I-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
that	that	WDT	B-NP	O
would	would	MD	B-VP	O
last	last	VB	I-VP	O
about	about	IN	B-NP	O
thirty	thirty	CD	I-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
occurred	occur	VBD	B-VP	O
several	several	JJ	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
or	or	CC	I-NP	O
syncope	syncope	NN	I-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
cardiology	cardiology	NN	B-NP	O
clinic	clinic	NN	I-NP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Hupp	Hupp	NNP	I-NP	O
where	where	WRB	B-ADVP	O
an	an	DT	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
162	162	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
100/60	100/60	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiology	cardiology	NN	I-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
coronary	coronary	JJ	I-NP	I-protein
artery	artery	NN	I-NP	I-protein
bypass	bypass	IN	B-PP	I-protein
graft	graft	NN	B-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
1995	1995	CD	B-NP	O
.	.	.	O	O

Vessels	Vessel	NNS	B-NP	O
bypassed	bypass	VBN	B-VP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
LIMA/LAD	LIMA/LAD	NN	I-NP	O
,	,	,	O	O
SVG/PDA	SVG/PDA	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
preceded	precede	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
first	first	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
1995	1995	CD	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
stenosis	stenosis	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
stenosis	stenosis	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
PCI	PCI	NN	B-NP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
vessels	vessel	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intervening	intervening	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
recathed	recathe	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
restenosis	restenosis	NN	B-NP	O
leading	lead	VBG	B-VP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
neuropathy	neuropathy	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
and	and	CC	I-NP	O
depression	depression	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Pravachol	Pravachol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
Elavil	Elavil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
allopurinol	allopurinol	NN	B-NP	O
3	3	CD	I-NP	O
x	x	NN	I-NP	O
week	week	NN	I-NP	O
;	;	:	O	O
Toprol	Toprol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Accupril	Accupril	NNP	B-NP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Xanax	Xanax	NN	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
husband	husband	NN	I-NP	O
died	die	VBD	B-VP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
retired	retire	VBN	I-NP	O
Cho	Cho	NNP	I-NP	O
S	S	NNP	I-NP	O
Ache	Ache	NNP	I-NP	O
policeman	policeman	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heavy	heavy	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
currently	currently	RB	B-ADVP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
E	E	NNP	I-NP	O
Lane	Lane	NNP	I-NP	O
,	,	,	O	O
Ma	Ma	NNP	B-NP	O
,	,	,	O	O
Arizona	Arizona	NNP	B-NP	O
97322	97322	CD	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
daughter	daughter	NN	I-NP	O
who	who	WP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
Cosa	Cosa	NNP	B-NP	O
Lare	Lare	NNP	I-NP	O
Stin	Stin	NNP	I-NP	O
PHYSICAL	PHYSICAL	NNP	I-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.6	98.6	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
100/60	100/60	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
flat	flat	JJ	B-ADJP	O
at	at	IN	B-PP	O
45	45	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
laterally	laterally	RB	I-NP	O
displaced	displace	VBN	I-NP	O
PMI	PMI	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
split	split	JJ	B-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Lower	Lower	JJ	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Cranial	Cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II-XII	II-XII	NN	I-NP	B-protein
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Electrocardiogram	Electrocardiogram	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
bundle	bundle	NN	B-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
or	or	CC	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
72-year-old	72-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
wide	wide	JJ	B-NP	O
complex	complex	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Cardiovascular	Cardiovascular	JJ	I-NP	O
-	-	HYPH	I-NP	O
Ischemia	Ischemia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abnormal	abnormal	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
her	her	PRP$	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
catheterization	catheterization	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	O	O
initially	initially	RB	B-VP	O
held	hold	VBD	I-VP	O
her	her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
while	while	IN	B-SBAR	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
controlling	control	VBG	I-VP	O
her	her	PRP$	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
hypotensive	hypotensive	JJ	I-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
so	so	IN	B-SBAR	O
we	we	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
held	hold	VBD	B-VP	O
her	her	PRP	B-NP	O
Accupril	Accupril	NNP	I-NP	O
as	as	IN	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
as	as	IN	B-PP	O
having	have	VBG	B-VP	O
Class	Class	NN	B-NP	O
II	II	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
admit	admit	VB	I-VP	O
to	to	TO	B-PP	O
not	not	RB	B-VP	O
being	be	VBG	I-VP	O
very	very	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
exerted	exert	VBD	B-VP	O
herself	herself	PRP	B-NP	O
more	more	JJR	B-ADJP	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
more	more	JJR	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
her	her	PRP$	B-NP	O
catheterization	catheterization	NN	I-NP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
31	31	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
thick	thick	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
and	and	CC	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
exhibit	exhibit	VB	I-VP	O
any	any	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
kept	keep	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
liter	liter	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
soon	soon	RB	B-VP	O
began	begin	VBD	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
admit	admit	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
drank	drink	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
larger	large	JJR	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
quite	quite	RB	B-ADJP	O
hypovolemic	hypovolemic	JJ	I-ADJP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
what	what	WP	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
normally	normally	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-PP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
we	we	PRP	B-NP	O
liberalized	liberalize	VBD	B-VP	O
her	her	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
normalized	normalize	VBD	B-VP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBD	B-VP	O
her	her	PRP$	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
later	later	RB	B-ADVP	O
that	that	IN	B-SBAR	O
evening	even	VBG	B-VP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
back	back	RB	B-ADVP	O
into	into	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
stayed	stay	VBN	I-VP	O
in	in	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
often	often	RB	B-ADVP	O
reaching	reach	VBG	B-VP	O
the	the	DT	B-NP	O
130s	130	NNS	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s/50s	90s/50	NNS	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x	x	NN	I-NP	O
1	1	CD	B-NP	O
over	over	IN	I-NP	O
20	20	CD	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
for	for	IN	B-PP	O
five	five	CD	B-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-ADVP	O
her	her	PRP$	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
progressed	progress	VBN	B-VP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
10-15	10-15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
symptomatic	symptomatic	JJ	B-ADJP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
and	and	CC	B-PP	O
after	after	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
phlebitis	phlebitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
VTAC	VTAC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
primarily	primarily	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
ischemic	ischemic	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
discussed	discuss	VBD	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
reluctant	reluctant	JJ	B-ADJP	O
but	but	CC	O	O
ultimately	ultimately	RB	B-VP	O
agreed	agree	VBD	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
also	also	RB	I-VP	O
discuss	discuss	VB	I-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
EP	EP	NN	I-NP	O
study	study	NN	I-NP	O
and	and	CC	I-NP	O
ablation	ablation	NN	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
preferred	prefer	VBD	B-VP	O
the	the	DT	B-NP	O
least	least	JJS	I-NP	O
invasive	invasive	JJ	I-NP	O
method	method	NN	I-NP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
compensated	compensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
exert	exert	VB	I-VP	O
herself	herself	PRP	B-NP	O
any	any	DT	B-ADVP	O
further	further	RBR	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
year	year	NN	I-NP	O
or	or	CC	I-NP	O
two	two	CD	I-NP	O
,	,	,	O	O
decompensate	decompensate	VBP	B-VP	O
and	and	CC	I-VP	O
have	have	VBP	I-VP	O
more	more	JJR	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
disease	disease	NN	I-NP	O
a	a	DT	B-NP	O
dual-chamber	dual-chamber	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
ICD	ICD	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
her	her	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
q.d.	q.d.	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
more	more	JJR	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
VTAC	VTAC	NN	B-NP	B-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
kept	keep	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
same	same	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
units	unit	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
and	and	CC	O	O
covered	cover	VBD	B-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
phlebitis	phlebitis	NN	B-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
quickly	quickly	RB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
what	what	WP	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
limited	limit	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
could	could	MD	B-VP	O
choose	choose	VB	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
prolong	prolong	VB	I-VP	O
her	her	PRP$	B-NP	O
QT	QT	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	I-NP	O
Elavil	Elavil	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
reported	report	VBN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
more	more	JJR	I-NP	O
details	detail	NNS	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
we	we	PRP	B-NP	O
gave	give	VBD	B-VP	O
her	her	PRP	B-NP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
speciated	speciate	VBN	I-VP	O
to	to	TO	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Rheumatology	Rheumatology	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gout	gout	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
did	do	VBD	B-VP	O
offer	offer	NN	B-NP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
VNA	VNA	NN	B-NP	B-protein
but	but	CC	O	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
and	and	CC	I-VP	O
felt	feel	VBD	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
needs	need	NNS	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
met	meet	VBN	I-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
's	's	POS	B-NP	O
house	house	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
sure	sure	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
move	move	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
eventually	eventually	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Ba	Ba	NNP	I-NP	O
or	or	CC	B-PP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
to	to	TO	I-VP	O
sell	sell	VB	I-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
and	and	CC	O	O
move	move	VB	B-VP	O
closer	closer	RBR	B-ADVP	O
to	to	TO	B-PP	O
family	family	NN	B-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Stuber	Stuber	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Buhr	Buhr	NNP	I-NP	O
She	She	NNP	I-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Pravachol	Pravachol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Elavil	Elavil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
;	;	:	O	O
NPH	NPH	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
q.	q.	NN	B-NP	O
p.m.	p.m.	NN	I-NP	O
;	;	:	O	O
allopurinol	allopurinol	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
Wednesday	Wednesday	NNP	B-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
;	;	:	O	O
Glucotrol	Glucotrol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
once	once	RB	I-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Toprol	Toprol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Accupril	Accupril	NNP	B-NP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
digoxin	digoxin	NN	B-NP	O
0.0625	0.0625	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Keflex	Keflex	NNP	B-NP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
x	x	FW	I-NP	O
2	2	CD	I-NP	O
doses	dose	NNS	I-NP	O
;	;	:	O	O
cefpodoxime	cefpodoxime	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	FW	I-NP	O
x	x	FW	I-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
note	note	VBP	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
digoxin	digoxin	NN	I-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
0.125	0.125	CD	B-NP	O
to	to	TO	B-PP	O
0.0625	0.0625	CD	B-NP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
AVERY	AVERY	NNP	B-NP	O
F.	F.	NNP	I-NP	O
MOLCHAN	MOLCHAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WES	WES	NNP	I-NP	O
MEMORIAL	MEMORIAL	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FREEMAN	FREEMAN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
KALAR	KALAR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PSH	PSH	NNP	I-NP	O
IE251/026054	IE251/026054	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
47255	47255	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

ZQAM9A1TB4	ZQAM9A1TB4	NN	B-NP	O
March	March	NNP	I-NP	O
August	August	NNP	I-NP	O

